Low Carb Down Under | Dr. Paul Mason - 'The shady truth about statins' @lowcarbdownunder | Uploaded December 2022 | Updated October 2024, 1 day ago.
This lecture is part 2 of 3 delivered by Dr Mason at the Low Carb Down Under Gold Coast conference in October 2022. Dr Mason exposes the catastrophic harms caused by the first cholesterol lowering drug, Triparanol, and the guilty verdict that followed.
This is followed by a brief history of statins, including the high rates of cancer in test animals seen with the first statin to come to market, and the massive (+$1,000,000,000) legal payouts made to settle lawsuits from statin side effects.
Specific statin side effects, including dementia are covered, followed by a close analysis of the measurable benefits that may be attributed to statins. This includes a review of a recent paper co-authored by David Diamond, Ben Bikman and Paul Mason that discusses how to identify who is likely and not likely to benefit from statin therapy using triglyceride and LDL levels.
journals.lww.com/co-endocrinology/fulltext/2022/10000/statin_therapy_is_not_warranted_for_a_person_with.14.aspx
Dr Paul Mason obtained his medical degree with honours from the University of Sydney. He is also a fellow of the Australasian College of Sports and Exercise Physicians, holds a Bachelor's degree in Physiotherapy and a Masters degree in Occupational Health. He is currently Chief Medical Officer of the Defeat Diabetes program, an evidence-based program focussed on lifestyle management of metabolic illnesses, including type 2 diabetes.
Please consider supporting Low Carb Down Under via Patreon. A small monthly contribution will assist in the costs of filming and editing these presentations and will allow us to keep producing high quality content free from advertising. For further information visit; patreon.com/lowcarbdownunder
This lecture is part 2 of 3 delivered by Dr Mason at the Low Carb Down Under Gold Coast conference in October 2022. Dr Mason exposes the catastrophic harms caused by the first cholesterol lowering drug, Triparanol, and the guilty verdict that followed.
This is followed by a brief history of statins, including the high rates of cancer in test animals seen with the first statin to come to market, and the massive (+$1,000,000,000) legal payouts made to settle lawsuits from statin side effects.
Specific statin side effects, including dementia are covered, followed by a close analysis of the measurable benefits that may be attributed to statins. This includes a review of a recent paper co-authored by David Diamond, Ben Bikman and Paul Mason that discusses how to identify who is likely and not likely to benefit from statin therapy using triglyceride and LDL levels.
journals.lww.com/co-endocrinology/fulltext/2022/10000/statin_therapy_is_not_warranted_for_a_person_with.14.aspx
Dr Paul Mason obtained his medical degree with honours from the University of Sydney. He is also a fellow of the Australasian College of Sports and Exercise Physicians, holds a Bachelor's degree in Physiotherapy and a Masters degree in Occupational Health. He is currently Chief Medical Officer of the Defeat Diabetes program, an evidence-based program focussed on lifestyle management of metabolic illnesses, including type 2 diabetes.
Please consider supporting Low Carb Down Under via Patreon. A small monthly contribution will assist in the costs of filming and editing these presentations and will allow us to keep producing high quality content free from advertising. For further information visit; patreon.com/lowcarbdownunder
